Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression

Anticancer Research

Volumn 34, Issue 12, 2014, Pages 7061-7069

  Umbreit, Claudia ^a   Flanjak, Julia ^a   Weiss, Christel ^b   Erben, Philipp ^b   Aderhold, Christoph ^a   Faber, Anne ^a   Stern Straeter, Jens ^a   Hoermann, Karl ^a   Schultz, Johannes David ^a  

^a Departments of Otorhinolaryngology Head and Neck Surgery   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

E cadherin; ECM; EGF; EMT.; Epithelial growth factor; Epithelial mesenchymal transition; Extracellular matrix; Head and neck squamous cell carcinoma; HNSCC; HPV; Human papillomavirus; P16 positive SCC; SCC; Squamous cell cancer; TGF 1; Transforming growth factor 1; Vimentin; catenin

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR; PROTEIN P16; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN; CADHERIN; P16 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PHENOTYPE; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA CELL; BIOSYNTHESIS; CELL ADHESION; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; IMMUNOHISTOCHEMISTRY; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

BETA CATENIN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84918548188     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Cardesa A and Nadal A: Carcinoma of the head and neck in the HPV era. Acta dermatovenerol Alp Pannonica Adriat 20(3): 161-173, 2011.
2. Dorsey K and Agulnik M: Promising new molecular targeted therapies in head and neck cancer. Drugs 73(4): 315-325, 2013.
3. Sudhoff HH, Schwarze HP, Winder D, Steinstraesser L, Gner M, Stanley M and Goon PK: Evidence for a causal association for HPV in head and neck cancers. Eur Arch Otorhinolaryngol 268: 1541-1547, 2011.
4. Kreimer AR, Clifford GM, Boyle P and Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiology Biomarkers Prev 14: 467-475, 2005.
5. Schultz JD, Sommer JU, Hoedt S, Erben P, Hofheinz RD, Faber A, Thorn C, Hormann K and Sauter A: Chemotherapeutic alteration of beta-catenin and c-kit expression by imatinib in p16-positive squamous cell carcinoma compared to HPVnegative HNSCC cells in vitro. Oncol Rep 27: 270-280, 2012.
6. Assmann G and Sotlar K: HPV-associated squamous cell carcinogenesis. [Article in German]. Pathologe 32: 391-398, 2011.
7. Hay ED: The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233: 706-720, 2005.
8. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005.
9. Krisanaprakornkit S and Iamaroon A: Epithelial-mesenchymal transition in oral squamous cell carcinoma. ISRN Oncology 2012: 681469, 2012.
10. Al Moustafa AE, Achkhar A and Yasmeen A: EGF-receptor signaling and epithelial-mesenchymal transition in human carcinomas. Front Biosci (Schol Ed) 4: 671-684, 2012.
11. Chang JY, Wright JM and Svoboda KK: Signal transduction pathways involved in epithelial-mesenchymal transition in oral cancer compared with other cancers. Cells Tissues Organs 185: 40-47, 2007.
12. Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelialmesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172: 973-981, 2006.
13. Yang ZC, Yi MJ, Ran N, Wang C, Fu P, Feng XY, Xu L and Qu ZH: Transforming growth factor-beta1 induces bronchial epithelial cells to mesenchymal transition by activating the Snail pathway and promotes airway remodeling in asthma. Mol Med Rep 8: 1663-1668, 2013.
14. Acevedo VD, Gangula RD, Freeman KW, Li R, Zhang Y, Wang F, Ayala GE, Peterson LE, Ittman M and Spencer DM: Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer cell 12: 559-571, 2007.
15. Padua D and Massague J: Roles of TGFbeta in metastasis. Cell Res 19: 89-102, 2009.
16. Iamaroon A, Pattamapun K and Piboonniyom SO: Aberrant expression of Smad4, a TGF-beta signaling molecule, in oral squamous cell carcinoma. J Oral Sci 48: 105-109, 2006.
17. Roberts AB and Wakefield LM: The two faces of transforming growth factor beta in carcinogenesis. Pro Natl Acad Sci USA 100: 8621-8623, 2003.
18. Richter P, Umbreit C, Franz M, Berndt A, Grimm S, Uecker A, Bohmer FD, Kosmehl H and Berndt A: EGF/TGFbeta1 costimulation of oral squamous cell carcinoma cells causes an epithelial-mesenchymal transition cell phenotype expressing laminin 332. J Oral Pathol Med 40: 46-54, 2011.
19. Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A and Kirchner T: Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymalepithelial transition, stem cells and beta-catenin. Cells Tissues Organs 179: 56-65, 2005.
20. Gilchrist AJ, Meuser R, Turchinsky J, Shaw AR, Pasdar M and Dixon WT: Cell adhesion-mediated transformation of a human SCLC cell line is associated with the development of a normal phenotype. Exp Cell Res 276: 63-78, 2002.
21. Xue C, Plieth D, Venkov C, Xu C and Neilson EG: The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 63: 3386-3394, 2003.
22. Turley EA, Veiseh M, Radisky DC and Bissell MJ: Mechanisms of disease: epithelial-mesenchymal transition-does cellular plasticity fuel neoplastic progression? Nat Clin Pract Oncol 5: 280-290, 2008.
23. Ahmed N, Maines-Bandiera S, Quinn MA, Unger WG, Dedhar S and Auersperg N: Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 290: C1532-1542, 2006.
24. Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ, Wan XX, He QY, Li JH, Qu JQ, Chen Y and Xiao ZQ: Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem 112: 2508-2517, 2011.
25. Cai Z, Zhou Y, Lei T, Chiu JF and He QY: Mammary serine protease inhibitor inhibits epithelial growth factor-induced epithelial-mesenchymal transition of esophageal carcinoma cells. Cancer 115: 36-48, 2009.
26. Rodrigues IS, Lavorato-Rocha AM, de MMB, Stiepcich MM, de Carvalho FM, Baiocchi G, Soares FA and Rocha RM: Epithelialmesenchymal transition-like events in vulvar cancer and its relation with HPV. Br J Cancer 109: 184-194, 2013.
27. Wakisaka N, Yoshida S, Kondo S, Kita M, Sawada-Kitamura S, Endo K, Tsuji A, Nakanish Y, Murono S and Yoshizaki T: Induction of epithelial-mesenchymal transition and loss of podoplanin expression are associated with progression of lymph node metastases in human papillomavirus-related oropharyngeal carcinoma. Histopathology 2014.
28. Narayanan R, Kim HN, Narayanan NK, Nargi D and Narayanan B: Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels. Int J Oncol 40: 13-20, 2012.
29. Hajra KM and Fearon ER: Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34: 255-268, 2002.
30. Klussmann JP, Preuss SF and Speel EJ: Human papillomavirus and cancer of the oropharynx. Molecular interaction and clinical implications. [Article in German]. Hno 57: 113-122, 2009.
31. Scanlon CS, Van Tubergen EA, Inglehart RC and DSilva NJ: Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res 2(92): 114-121, 2013.
32. Koontongkaew S: The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. J Cancer 4: 66-83, 2013.
33. Seiki M: Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 194: 1-11, 2003.
34. Lamouille S, Xu J and Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15: 178-196, 2014.
35. Valenta T, Hausmann G and Basler K: The many faces and functions of beta-catenin. EMBO J 31: 2714-2736, 2012.
36. Sahu N and Grandis JR: New advances in molecular approaches to head and neck squamous cell carcinoma. Anticancer Drugs 22: 656-664, 2011.
37. Smilek P, Neuwirthova J, Jarkovsky J, Dusek L, Rottenberg J, Kostrica R, Srovnal J, Hajduch M, Drabek J and Klozar J: Epidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomas. Neoplasma 59: 508-515, 2012.
38. Ciardiello F and Tortora G: Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs. Eur J Cancer 39: 1348-1354, 2003.
39. Tang AL, Hauff SJ, Owen JH, Graham MP, Czerwinski MJ, Park JJ, Walline H, Papagerakis S, Stoerker J, McHugh JB, Chepeha DB, Bradford CR, Carey TE and Prince ME: UM-SCC-104: a new human papillomavirus-16-positive cancer stem cellcontaining head and neck squamous cell carcinoma cell line. Head Neck 34: 1480-1491, 2012.
40. Mirghani H, Amen F, Moreau F, Guigay J, Ferchiou M, Melkane AE, Hartl DM, Lacau ST and Guily J: Human papilloma virus testing in oropharyngeal squamous cell carcinoma: what the clinician should know. Oral Oncol 50: 1-9, 2014.
41. Al Moustafa AE, Foulkes WD, Benlimame N, Wong A, Yen L, Bergeron J, Batist G, Alpert L and Alaoui-Jamali MA: E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Oncogene 23: 350-358, 2004.
42. Boyer B, Tucker GC, Valles AM, Gavrilovic J and Thiery JP: Reversible transition towards a fibroblastic phenotype in a rat carcinoma cell line. Int J Cancer Suppl 4: 69-75, 1989.
43. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H and Mori M: Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101: 293-299, 2010.
44. Thomson S, Buck E, Petti F, Griffin G, Brown E, Ramnarine N, Iwata KK, Gibson N and Haley JD: Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res 65: 9455-9462, 2005.
45. Frederick BA, Helfrich BA, Coldren CD, Zheng D, Chan D, Bunn PA Jr. and Raben D: Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma. Mol Cancer Ther 6: 1683-1691, 2007.
46. Fuchs BC, Fujii T, Dorfman JD, Goodwin JM, Zhu AX, Lanuti M and Tanabe KK: Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res 68: 2391-2399, 2008.
47. Maseki S, Ijichi K, Tanaka H, Fujii M, Hasegawa Y, Ogawa T, Murakami S, Kondo E and Nakanishi H: Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3beta/snail signalling pathway. Br J Cancer 106: 1196-1204, 2012.
48. Fan L, Sebe A, Peterfi Z, Masszi A, Thirone AC, Rotstein OD, Nakano H, McCulloch CA, Szaszi K, Mucsi I and Kapus A: Cell contact-dependent regulation of epithelial-myofibroblast transition via the rho-rho kinase-phospho-myosin pathway. Mol Biol Cell 18: 1083-1097, 2007.